The Food and Drug Administration (FDA) performed an inspection at Bioresource Technology, Inc. in Weston on April 9, reviewing the company’s practices related to blood and blood products, according to data posted on the FDA’s website.
The inspection report concluded that Bioresource Technology, Inc. was not required to make any changes to how it conducts its operations.
The FDA regularly inspects facilities nationwide to verify that workplaces and their products adhere to federal laws and regulations aimed at protecting public health. Results of these inspections are made available to the public.
According to its website, the FDA is a government agency chiefly responsible for overseeing the safety and quality of human and animal drugs, biological products, medical devices and tobacco products.
Information in this article was obtained from the U.S. Food and Drug Administration. The source data can be found here.
